Skip Navigation

US$280 in China, US$8,892 in the US: new Chinese cancer drug gets FDA approval

www.scmp.com US$280 in China, US$8,892 in the US: new Chinese cancer drug gets FDA approval

Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.

Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.

10
United States | News & Politics @lemmy.ml ☆ Yσɠƚԋσʂ ☆ @lemmy.ml
China’s new cancer drug Toripalimab is approved in the US but will cost 30 times more
10 comments
10 comments